The prognostic value of cardiopulmonary exercise testing

Symposium
Chairs: L. Puente Maestú (Madrid, Spain), P. Palange (Rome, Italy)
Aims: The audience will be introduced to and updated on the evidence supporting the use of cardiopulmonary exercise testing as a prognostic tool.

The survival of the fittest: maximal oxygen uptake and survival overview J. Myers (Palo Alto, United States of America)
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis K. Flaherty (Ann Arbour, United States of America)
Prediction of mortality: what variables should we consider? M. Puhan (Zurich, Switzerland)